Search

everythinglearnresearchcommunity

for

Search:↓

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Murine cytomegalovirus does not cause alopecia areata in these mice.

Hair growth in alopecia areata is hindered due to impaired cell activity in the surrounding tissue.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

People with alopecia areata have a higher risk of stroke.

Erlotinib can cause hair loss as a side effect.

Glycyrrhizin nanocarriers effectively deliver baicalin to hair follicles, promoting hair growth and offering a promising alopecia treatment with fewer side effects.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Minoxidil in HA-PLGA nanoparticles effectively treats alopecia through skin delivery.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Botulinum toxin type A injections are not effective for severe alopecia areata.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

Gene linked to common hair loss found, may lead to new treatments.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.